- This event has passed.
Update in Head and Neck Cancer – Harvard Medical School
May 6, 2016 - May 7, 2016$500
Update in Head and Neck Cancer Course will provide practitioners who care for patients with malignant diseases of the head and neck region with a comprehensive overview of the current standard of care practices for management of disorders of this region as well as an introduction and review of evolving and innovative treatment approaches. Management recommendations are rapidly evolving in this era of increasing HPV-related disease and will receive particular attention, including a discussion of de-escalation and the current randomized trials evaluating de-escalation protocols. Distinguished faculty from within the Harvard Medical School system as well as from prominent programs nationally will present a series of didactic lectures and participate in open panels which cover the management of malignancies in critical subsites within the head and neck such as the oral cavity, oropharynx, larynx, salivary gland, and others. They will also discuss cutaneous cancers, endocrine malignancies, and skull-based cancers. Pertinent reconstructive and rehabilitative issues will similarly be addressed during specific sessions. The opening session will focus on the critical aspects of multidisciplinary management of head and neck cancer as it is currently evolving with presentations by national leaders from the specialties of otolaryngology – head and neck surgery, medical oncology and radiation oncology. This session will be highlighted by the Daniel Miller, MD Distinguished Lectureship in Head and Neck Cancer and the William Wayne Montgomery, MD Lectureship in Surgical Innovation.
Open interaction between faculty and participants will be encouraged throughout the course with particular emphasis during the scheduled “Tumor Board” sessions and Q&A periods. Participants will be encouraged to pre-submit cases for the Tumor board sessions to have these cases serve as a springboard for discussion.
Upon completion of this activity, participants will be able to:
- Describe the critical aspects of multidisciplinary evaluation, treatment and follow-up in the management of patients with head and neck malignancies with specific emphasis on the advances on organ preservation protocols and the evolving role of the head and neck surgeon in this era.
- Implement current standard of care diagnostic and treatment protocols for common head and neck cancer subsites of an oral cavity, oropharynx, larynx, salivary gland and cutaneous malignancies.
- Appreciate the critical importance of associated specialties, such as radiology, pathology, endocrinology, dermatology and speech and swallow rehabilitative services, in delivering the best care to patients with head and neck cancer.
- Synthesize innovations in basic science research, head and neck reconstruction, salivary gland cancer and thyroid cancer.
This course is targeted to physicians, physician assistants, nurses, and nurse practitioners. This course may also be of interest to specialty physicians who practice in Internal Medicine, Oncology and Hematology, Otolaryngology, Radiology and Nuclear Medicine, and Surgery.